IL6 and rheumatoid arthritis: SIgG4 decreased in 7 of 8 RA patients who received treatment of tocilizumab, a monoclonal antibody to the IL-6 receptor [30], indicating that IL-6 may be the principal cytokine that induces IgG4 elevation in RA.